美股A股
StockGist

U.S. Physical Therapy, Inc.

USPHNYSE · Healthcare · Medical - Care FacilitiesGARP
U.S.
$99.55+0.41%
报价 2026-11-16
市值
$1.49B
EV
$1.64B
PE (TTM)
493.9x
预期 PE (FY2026)
34.5x
52 周区间距高点 -0.5%
$59.00$100.10

筛选结果

pipeline · 2026-11-16
Keep✗ 高增长✗ Cheap✓ GARP
GARP Pool: growth 10-30%, P/FCF <= 20, MC/GP <= 11

爆发潜力

2026-11-16
未命中✗ 收入线✗ EPS 线
财年收入倍数EPSPE
FY+22027-121.1x2.68 → 3.38(1.3x)29.5
FY+32028-121.2x2.68 → 3.79(1.4x)26.2

毛利率 19% · TTM 收入 $838M · 基数 EPS 2.68(调整后)

研究结论

还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。

去生成基本面报告 →

历史股价

加载中…

事件

0 条 · 随区间与图例筛选

该区间内无事件。

同行对比

FMP 同行列表 · 2026-05-16
公司市值今日预期营收增速毛利率PEEV/EBITDAP/FCF池
USPHU.S. Physical Therapy, Inc.$1.49B+0.4%+10.3%19.6%493.9x16.3x19.9xGARP
NEOGNeogen Corporation$2.38B-3.1%+3.6%47.4%–31.6x54.7x
ZBIOZenas BioPharma, Inc.$1.89B-0.3%+13.3%0%–––
HCSGHealthcare Services Group, Inc.$1.68B-0.2%+6.1%16.8%16.3x11.6x15.2x
KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.$1.67B-2.3%+51.5%56.5%–––高增长
ASTHAstrana Health, Inc.$1.63B+3.4%+25.7%10.7%45.8x12.9x11.9x
CNMDCONMED Corporation$1.47B-2.5%-0.4%56.4%21.0x10.8x11.4x
PNTGThe Pennant Group, Inc.$1.3B+2.7%+27.4%13.3%35.4x23.6x50.4x
GDRXGoodRx Holdings, Inc.$1.2B-1.4%+0.6%89.5%69.4x8.7x8.5x
同行中位数––+9.7%32.1%35.4x12.2x13.5x

研究全文

L2 基本面 memo

尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。

财务报表

Metric
2026-06-30
Q2 2026
2026-03-31
Q1 2026
2025-12-31
Q4 2025
2025-09-30
Q3 2025
2025-06-30
Q2 2025
2025-03-31
Q1 2025
2024-12-31
Q4 2024
2024-09-30
Q3 2024
Revenue$214.1M$198.3M$202.7M$164M$164.2M$152.5M$180.4M$168M
Gross Margin19.6%14.5%20.7%22.5%25.4%20.4%18.7%17.3%
Operating Margin10.3%7.5%10.9%15.4%15.2%12.9%8.1%8.8%
Net Income$1.6M$-4.3M$-10.5M$7.2M$8.8M$9.9M$7.4M$5.5M
Diluted EPS0.25-0.12-0.440.480.580.80.520.39
Operating Cash Flow$34.2M$4M$24.9M$19.9M$34.9M$-4.7M$19.4M$22.1M

研究材料